The Biopharma 4.0 glossary

要約

Master the terminology shaping modern biomanufacturing with 50+ essential terms, from AI and automation to PAT and QbD.
Accelerate your learning and collaboration with clear, expert-sourced definitions tailored for scientists, engineers, and other Life Sciences professionals.
Stay aligned with industry standards using terminology informed by the FDA, EMA, BioPhorum, and other trusted sources.
Support digital transformation and team training with a free, easy-to-navigate glossary built for today’s biopharma challenges.

©Endress+Hauser

Navigating the evolving world of biopharma can be complex—especially when the language itself is constantly changing. That is why we created the Biopharma 4.0 glossary: a comprehensive, easy-to-use reference designed to help you understand the key terms, technologies, and trends shaping the future of biopharmaceutical manufacturing.

Why a biopharma glossary matters

As digital technologies like AI, automation, and real-time analytics become central to biopharmaceutical production, understanding the language of innovation is more important than ever. A shared vocabulary empowers teams to collaborate more effectively, make informed decisions, and accelerate progress across the product lifecycle.

What you will find inside

The Biopharma 4.0 glossary features over 50 essential terms and abbreviations—from foundational concepts like Quality by Design (QbD) and Critical Quality Attributes (CQAs) to advanced tools like digital twins, machine learning, and real-time release testing. Each definition is:

Clear and concise
Sourced from trusted industry leaders such as the FDA, EMA, and BioPhorum
Tailored for professionals at every staage of their career

Who is this glossary for?

This glossary is designed to support your learning and development journey, whether you are:

New to the biopharma industry
Deepening your technical expertise
Training a new team member
Leading a digital transformation initiative

How to use the glossary

Use it to:

Refresh your foundational knowledge
Onboard new colleagues
Support cross-functional collaboration
Stay aligned with evolving industry standards

Browse the Biopharma 4.0 glossary

Browse the Biopharma 4.0 glossary terms below or download the full guide to reference it anytime, at your convenience.

Advanced modalities & techniques

Messenger ribonucleic acid (mRNA)

Messenger ribonucleic acid (mRNA) is a single-stranded molecule transcribed from DNA that carries genetic instructions from the nucleus to the cytoplasm, where it guides the synthesis of proteins by translating codons into amino acids.

Miniaturization

Miniaturization is the process of reducing the size of a reaction mixture or assay.

Monoclonal antibodies (mAbs)

Monoclonal antibodies (mAbs) are a category of therapeutic biological products that are specialized immunoglobulins produced from a single cell line, each with a specific target.

Omics technology

Omics technology is a scientific approach associated with measuring biological molecules in a high-throughput way.

AI and machine learning

Artificial intelligence (AI)

Artifical intelligence is a machine-based system that can, for a given set of human-defined objectives, make predictions, recommendations, or decisions influencing real or virtual environments

Deep learning (DL)

Deep learning is a technique that involves finding a representation of data with multiple layers of abstraction using complex models that are composed of several layers of nonlinear computational units.

Hybrid data + AI process model

Hybrid data + AI process model is an approach that balances knowledge-based traditional modeling and data-based modeling offered by AI/ML to create more accurate and efficient representations of complex processes.

Machine learning (ML)

Machine learning is a set of techniques that can be used to train AI algorithms to improve performance at a task based on data.

Bioprocess design & engineering

Agile manufacturing

Agile manufacturing is a flexible and adaptable approach to producing personalized drugs and medicine to meet patient needs.

Biopharma 4.0

Biopharma 4.0 is a comprehensive term that integrates diverse applications of data and digital technologies in biotherapeutic manufacturing, also known as Bioprocessing 4.0.

Biopharma 5.0

Biopharma 5.0 is a new ideology where technology and human intelligence are integrated to address not only productivity and profitability, but also environmental and societal challenges.

Continuous bioprocessing

Continuous bioprocessing is the integration of multiple unit operations in biomanufacturing into a continuous, uninterrupted process flow.

Digital Plant Maturity Model (DPMM)

The Digital Plant Maturity Model (DPMM) is a structured and accessible framework for evaluating plant-wide digital maturity and establishing target levels that align with an organization’s overall digital strategy.

In-silico process development

In-silico process development is computational models that investigate pharmacological hypotheses using methods such as databases, data analysis tools, data mining, homology models, machine learning, pharmacophores, quantitative structure-activity relationships, and network analysis.

Multi-use systems

Multi-use systems are conventional stainless-steel systems that undergo cleaning and sterilization between uses; commonly used in large-scale, high-throughput operations; valued for their durability and reusability, but require extensive infrastructure for cleaning, validation, and ongoing maintenance.

Process intensification

Process intensification is an approach that strives for more efficient conversion of raw materials into products while minimizing resource usage in biopharmaceutical production.

Robotics

Robotics is a branch of technology that deals with the design, construction, operation, and application of robots which involves various advanced manufacturing techniques and often incorporates automation to enhance efficiency in production processes.

Single-use systems

Single-use systems are types of biopharmaceutical processing systems that are designed for use during the production of a single batch of therapeutics and then discarded, including components such as single-use bioreactors (SUBs).

Data and analytics

Cloud-based data storage

Cloud-based storage is a model where data is stored and analyzed remotely in cloud environments, as opposed to being downloaded and stored locally.

Computational chemistry

Computational chemistry is the use of computer simulations and modeling techniques to study and predict the behavior of molecules relevant to drug development.

Cybersecurity

Cybersecurity is the protection of digital systems, data, and infrastructure used in drug development, manufacturing, and regulatory compliance from unauthorized access, cyberattacks, and data breaches.

Data analytics

Data analytics is data generated throughout the biopharmaceutical production lifecycle that is processed and interpreted to allow for data-driven decisions.

Data lakes

Data lakes are centralized repositories that store structured and unstructured data at any scale.

Data science

Data science is a core discipline in biopharmaceutical research combining data, computing power, and advanced analytics.

Digital fluency/literacy

Digital fluency/literacy is possessing a strong proficiency in data analysis, cloud computing, cybersecurity, and other newer emerging digital technologies.

Digital twin

A digital twin is a virtual replica of a physical object, process, or system that uses real-time data to simulate its behavior.

Harmonized data strategy

A harmonized data strategy is a coordinated and standardized approach to managing data across the entire product lifecycle, ensuring consistency, integrity, and compliance across global operations.

Predictive analytics

Predictive analytics is data processed and interpreted throughout the
biopharmaceutical production lifecycle that is used to anticipate issues before they arise for proactive quality management and process optimization.

Production monitoring & control

Cell line development (CLD)

Cell line development (CLD) is the engineering of a cell line, often mammalian, to produce a therapeutic biomolecule or biologic.

Critical material attribute (CMA)

Critical material attribute (CMA) is a physical, chemical, biological, or microbiological property or characteristic of an input material that must be within an appropriate limit, range, or distribution to ensure the desired quality of the output material or final drug product.

Critical process parameter (CPP)

Critical process parameter (CPP) is a key variable in a manufacturing process that must be controlled within specific limits to ensure the process consistently produces a product of the desired quality.

Critical quality attribute (CQA)

Critical quality attribute (CQA) is physical, chemical, biological, or microbiological property or characteristic of a drug product, intermediate, or raw material that must be within an appropriate limit, range, or distribution to ensure the final product meets its intended safety, efficacy, and quality.

Operational technology (OT)

Operational technology (OT) is hardware and software systems used to monitor and control physical processes. OT integrates with Information Technology (IT) systems to enable real-time data-driven decision making and smart automation.

Pharma 4.0

Pharma 4.0 is the utilization of advanced technologies like artificial intelligence (AI), Internet of Things (IoT), and data analytics to enhance and optimize the manufacturing processes in the pharmaceutical industry.

Quality target product profile (QTPP)

A quality target product profile (QTPP) is a prospective summary of the desired quality characteristics of a drug product, identifying its Critical Quality Attributes (CQAs) to ensure safety, efficacy, and serving as the foundation for product development and design.

Real-time release testing (RTRT)

Real-time release testing (RTRT) is the ability to evaluate and ensure the quality of in-process and/or final drug product based on process data, which typically includes a validated combination of measured material attributes and process controls.

Regulatory and compliance

European Medicines Agency (EMA)

The European Medicines Agency (EMA) is a decentralized operating entity within the European Union (EU) with primary duties that include the scientific assessment, oversight, and safety monitoring of pharmaceuticals.

Integrated evidence generation planning (IEGP)

Integrated evidence generation planning (IEGP) is a strategic roadmap that aligns scientific, medical regulatory, health economics and outcomes research, market access and commercial objectives for pharmaceutical products.

Integrated evidence generation plan (IEP)

Integrated evidence generation plan (IEP) is accounting for the evidence needs of different functions and geographies across the life cycle of an asset, and then collaboratively determining how to meet them using a broad range of methods and data.

International Society for Pharmaceutical Engineering (ISPE)

The International Society for Pharmaceutical Engineering (ISPE) is a nonprofit organization dedicated to supporting its members by spearheading scientific, technical, and regulatory progress across the entire pharmaceutical lifecycle.

Process analytical technology (PAT)

Process analytical technology (PAT) is a system used to design, monitor, and control biopharmaceutical manufacturing by measuring key quality and performance attributes of materials and processes in real time to ensure consistent product quality.

Quality by Design (QbD)

Quality by Design (QbD) is a structured, proactive approach to product development and manufacturing that emphasizes designing quality into processes from the beginning, rather than relying solely on testing after production.

The International Council for Harmonisation (ICH)

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global council that brings together regulatory authorities and the pharmaceutical industry from around the world to develop harmonized guidelines for the pharmaceutical sector.

U.S. Food and Drug Administration (FDA)

The U.S. Food and Drug Administration (FDA) is a federal agency responsible for safeguarding public health by ensuring that food, cosmetics, and other consumer products are safe, effective, and accurately labeled.

Technologies and tools

Automation

Automation is the use of integrated advanced technologies and robotics to improve the efficiency and productivity of the biopharmaceutical manufacturing process.

Blockchain

Blockchain is a decentralized ledger system used for authenticating the information entered onto it, assuring product integrity from the point of origin to destination and real-time information in supply chain bottlenecks.

Disruptive innovation

A disruptive innovation is introducing a product, service, or business model that significantly alters the way a sector operates, often challenging established market leaders and products.

Electronic lab notebook (ELN)

An electronic lab notebook (ELN) is a software tool intended to replicate an interface much like a paper lab notebook that allows users to create, store, and share scientific records electronically.

Internet of Things (IoT)

The Internet of Things (IoT) is the integration of smart sensors, devices, and advanced analytics into biopharmaceutical processes.

Laboratory Information Management Systems (LIMS)

Laboratory Information Management Systems (LIMS) is software to effectively automate workflows, integrate instruments, and manage samples and associated information.

Next generation sequencing (NGS)

Next generation sequencing (NGS) is a massively parallel sequencing technology that offers ultra-high throughput, scalability, and speed.

Raman spectroscopy

Raman spectroscopy is an optical analysis technique that measures the chemical composition of samples using optical radiation interacting with molecular vibrations, resulting in the exciting radiation becoming inelastically scattered.

Download the Biopharma 4.0 glossary

Get a free downloadable

The Biopharma 4.0 glossary is available as a free resource to support continuous learning in the Life Sciences. Download this easy reference guide to upskill your expertise, stay ahead in your field, train a colleague, or just get a quick refresher of essential Biopharma 4.0 terminology.

Download the glossary

注釈

Explore our Raman spectroscopy biopharma portfolio

シンプルな製品
選定、設置、操作が簡単

技術的卓越性

シンプルさ

FLEXとは？

標準的製品
高い信頼性と堅牢性、容易なメンテナンス

技術的卓越性

シンプルさ

FLEXとは？

ハイエンド製品
高性能で高い利便性

技術的卓越性

シンプルさ

FLEXとは？

特殊仕様の製品
要件の厳しいアプリケーション向けに設計

技術的卓越性

シンプルさ

高い柔軟性

FLEXとは？

FLEX セレクション	技術的卓越性	シンプルさ
F L E X Fundamental セレクション基本的な測定要件に対応	技術的卓越性	シンプルさ
F L E X Lean セレクションコアプロセスの要件に対応	技術的卓越性	シンプルさ
F L E X Extended セレクション革新的な技術でプロセスを最適化	技術的卓越性	シンプルさ
F L E X Xpert セレクション最も困難なアプリケーションにも対応	技術的卓越性	シンプルさ高い柔軟性